✦ LIBER ✦

Is the outcome of rheumatoid arthritis changed with the use of new disease-modifying antirheumatic drugs?

✍ Scribed by Kremer, Joel

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 46 KB
Volume: 53
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.21447

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The early use of disease-modifying antir

The early use of disease-modifying antirheumatic drugs in rheumatoid arthritis

✍ Edward S. Mongan 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Use of nonbiologic disease-modifying ant

Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis

✍ Lacaille, Diane ;Guh, Daphne P. ;Abrahamowicz, Michal ;Anis, Aslam H. ;Esdaile, 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

Changes in cotherapies after initiation

Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis

✍ Vivian K. Kawai; Carlos G. Grijalva; Patrick G. Arbogast; Jeffrey R. Curtis; Dan 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 392 KB 👁 2 views

American College of Rheumatology 2008 re

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

✍ Saag, Kenneth G. ;Teng, Gim Gee ;Patkar, Nivedita M. ;Anuntiyo, Jeremy ;Finney, 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB 👁 2 views

Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be v

The importance of the disease process an

The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis

✍ Edwards, Christopher J. ;Cooper, Cyrus ;Fisher, David ;Field, Max ;van Staa, Tje 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Interleukin-6 receptor inhibition with t

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

✍ Mark C. Genovese; James D. McKay; Evgeny L. Nasonov; Eduardo F. Mysler; Nilzio A 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views